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Abstract
Purpose: Osteochondral allograft (OCA) transplantation is a restorative technique for addressing articular cartilage
defects by transferring mature viable chondrocytes with subchondral bone into size-matched lesions. The purpose of
this study was to compare differences in clinical and functional outcomes in patients treated with OCA for osteochondral defects compared with isolated chondral pathology.
Methods: A retrospective review identified patients who underwent OCA transplantation and grouped them into
osteochondral or isolated chondral pathology. Demographic data, surgical history, lesion characteristics, complications, and rate of subsequent surgery were reviewed. The review included 86 patients (24 osteochondral, 62 chondral)
with a mean follow-up of 5.4 ± 1.4 years. Outcome measures included the Knee Injury and Osteoarthritis Outcome
Score for Joint Replacement (KOOS, JR.), International Knee Documentation Committee (IKDC), and Short Form Health
Survey (SF-12) physical scores. Failure was defined to include revision OCA, graft removal, conversion to ACI, or conversion to arthroplasty.
Results: The average age at surgery was 32.3 and 37.3 years for the osteochondral and chondral groups, respectively
(P = 0.056). The medial femoral condyle was the most common defect location in both groups. P < 0.05 was considered statistically significant. Patients with osteochondral pathology had significantly greater KOOS JR., IKDC, and SF-12
scores (P < 0.05), and fewer failures were reported in the osteochondral group (8.3% versus 32.3%, P = 0.045). When
controlling for age, sex, laterality, BMI, and presence of a concomitant procedure, patients with osteochondral pathology were found to have better KOOS and IKDC scores, but there was no difference in SF12 scores or rates of failure
between groups.
Conclusion: The findings of this study indicate that patients undergoing OCA for osteochondral defects may have
greater functional outcomes and similar failure rates compared with OCA transplantation for isolated chondral
pathology.
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Introduction
Chondral lesions are commonly encountered during
knee arthroscopic surgery, with a reported prevalence
of 63–66% [1]. Articular cartilage lesions can cause pain,
recurrent effusions, and functional impairment [2, 3]. Previous studies have demonstrated that unaddressed lesions
or excised fragments result in poor knee function and osteoarthritis [4]. There are several options available to address
focal chondral and osteochondral defects, including palliative options, such as chondroplasty, reparative with microfracture or fragment fixation, and restorative options, such
as autologous chondrocyte implantation (ACI), osteochondral autograft transfer (OAT), or osteochondral allograft
(OCA) transplantation [5–7]. Ultimately, treatment selection depends on a variety of factors including lesion characteristics, patient age, function, and concomitant pathology.
Previous studies have demonstrated that microfracture has
the best results in lesions < 2 cm2, whereas lesions between
2 and 4 cm2 can be addressed with ACI, OATs, or allograft
transplantation, and lesions > 4 cm2 with ACI or OCA [2,
13–15] Generally speaking, in lesions > 2 cm2 where bone
loss is present, osteochondral allograft can be a first-line
treatment [16].
The use of OCA has increased in recent years as new
studies have demonstrated satisfactory long-term outcomes with 5- and 10-year survival rates of 95% and 85%,
respectively [8–11]. However, there are several limitations
to the use of OCA, including donor tissue availability, contour matching, limited time from graft harvest to implantation, and potential for disease transmission [8, 12]. In large
uncontained chondral defects, defects with sclerotic subchondral bone, or subchondral bone loss, osteochondral
allograft may be a clearer choice. However, the use of OCA
in focal articular cartilage loss without subchondral bone
involvement is more controversial. The purpose of this
study was to compare differences between OCA for osteochondral defects compared with focal chondral lesions to
determine differences in outcomes and complications. We
hypothesized OCA for isolated chondral compared with
osteochondral defects would result in similar outcomes.
Materials and methods
After institutional review board approval (#0153),
patients who underwent OCA from January 2012 to
December 2016 at a single institution were identified via
a database query. A retrospective chart review of each
patient’s clinical and surgical history was performed, and
patients with more than 2 years follow-up were included.
Patients were excluded if their medical history revealed

Table 1 Comparison of demographic
osteochondral and chondral lesions

data

between

Osteochondral

Chondral

P-value

N = 24

N = 62

32.25 ± 11.06

37.30 ± 10.77

0.056

Male

17 (70.83%)

31 (50.00%)

0.081

Female

7 (29.17%)

31 (50.00%)

26.43

29.17

0.006*

Right

15 (62.50%)

26 (41.94%)

0.098

Left

9 (37.50%)

36 (58.06%)

Age at surgery, years
Sex

BMI, kg/m2
Laterality

Etiology
AVN

2 (8.3%)

OCD

22 (91.6%)

Acute trauma

33 (53.2%)

Focal DJD

27 (43.6%)

Chondromalacia patella

1 (1.6%)

Chondromalacia trochlea

1 (1.6%)

Grade
2

–

1 (1.66%)

3

2 (9.52%)

10 (16.66%)

4

19 (90.48%)

49 (81.66%)

3.90

3.80

Mean

0.234

BMI body mass index, AVN avascular necrosis, OCD osteochondritis dissecans,
DJD degenerative joint disease. *Values significant at P < 0.05

absence of 50% or more of the ipsilateral meniscus,
inflammatory arthropathy, or incomplete preoperative or
intraoperative history. A total of 118 patients were eligible for the study, but 32 were lost to follow-up, leaving 86
patients for final analysis. Patients were grouped according to disease etiopathogenesis. Those with a diagnosis
of osteochondritis dissecans or avascular necrosis were
placed into the osteochondral group, while the chondral
group had a diagnosis of trauma or focal degenerative
defect.
Twenty-four (27.9%) patients were diagnosed with
osteochondral pathology, 22 (91.7%) from osteochondritis dissecans and 2 (8.3%) secondary to avascular
necrosis. Sixty-two (72.1%) patients had isolated chondral pathology, further subdivided into acute trauma (33
patients, 53.2%), focal degenerative defect (27 patients,
43.6%), and chondromalacia of the trochlea (1 patient,
1.6%) and patella (1 patient, 1.6%). Demographic data,
including age, laterality, sex, and body mass index (BMI),
were recorded (Table 1).
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In our practice, most patients with osteochondral
pathology from osteochondritis dissecans are treated
with fresh OCA. For those with chondral pathology
only, it was at the surgeon’s discretion to perform fresh
OCA as opposed to an alternative treatment option such
as autologous chondrocyte implantation for the defect.
Overall, OCA transplantation was indicated for symptomatic younger patients with magnetic resonance imaging (MRI) evidence of focal defects measuring > 2 cm2
that failed to improve with conservative management
or patients requiring revision procedures if there was
no radiographic evidence of Kellgren–Lawrence grade 3
or 4 osteoarthritis. Full-length standing lower extremity
x-rays were obtained only in patients with clinical evidence of varus/valgus malalignment requiring osteotomy.
There was one patient in our study who required a high
tibial osteotomy with concomitant cartilage restoration. The OCA transplantation surgery was performed
through a medial or lateral parapatellar arthrotomy using
a press-fit cylindrical graft matched to the defect size. All
preoperative MRIs were reviewed for degree of pathology, lesion size, location, and involvement of subchondral bone. The operative notes were also reviewed for
similar details in addition any concomitant procedures
performed (Table 2). In total, 9 patients in the osteochondral group and 32 in the chondral group had concomitant
procedures. The mean lesion grade in the osteochondral
group was 3.9 compared with 3.8 for the chondral group
(P = 0.234). Pathology was grouped into four groups:
condylar (medial or lateral), patellar, trochlear (medial or
lateral), and multifocal.
Outcome measures included the Knee Injury and
Osteoarthritis Outcome Scores for Joint Replacement
(KOOS JR.), International Knee Documentation Committee (IKDC) evaluation, and Short Form Health Survey (SF-12) physical scores. In addition, the need for
subsequent surgery, complications, and failure rates
were recorded. Failure was defined to include revision
OCA, graft removal, conversion to ACI, or conversion to
arthroplasty.
Summary statistics, including mean and standard deviation, were calculated. The Shapiro–Wilk test was used
to determine normality of the data. The Mann–Whitney
U test was used to compare the means of two unpaired
groups for nonparametric data. The Kruskal–Wallis
test was used when comparing continuous data for two
groups with nonparametric data. The Fischer exact test
was used for categorical data. Statistical significance was
set to P < 0.05. A regression analysis was performed comparing failures and outcome measures while adjusting for
the confounding variables of, age, sex, laterality, BMI, and
presence of a concomitant procedure. Further, to control
for location of lesion, a separate univariate analysis was
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Table 2 Comparison of concomitant procedures between
osteochondral and chondral lesions
Osteochondral Chondral (N = 32)
(N = 9)
ACI

1 (11.1%)

–

ACLR

–

3 (9.4%)

ACLR + meniscal repair

–

1 (3.1%)

ACLR + meniscal transplant

–

2 (6.2%)

ACLR + TTO + meniscal repair

–

1 (3.1%)

Curettage and bone grafting

1 (11.1%)

–

Debridement/synovectomy

1 (11.1%)

3 (9.4%)

Fulkerson TTO

1 (11.1%)

7 (21.9%)

Fulkerson TTO + MPFLR

–

3 (9.4%)

High tibial osteotomy

1 (11.1%)

–

Lateral retinacular lengthening

–

1 (3.1%)

Meniscal transplant

1 (11.1%)

1 (3.1%)

Meniscectomy

1 (11.1%)

2 (6.3%)

Microfracture

2 (22.2%)

–

MPFLR + lateral retinacular
lengthening

–

5 (15.6%)

ROH

–

2 (6.3%)

TTO + meniscectomy

–

1

ACI autologous chondrocyte implantation, ACLR anterior cruciate reconstruction,
TTO tibial tubercle osteotomy, MPFLR medial patellofemoral ligament
reconstruction, ROH removal of hardware. Debridement includes lysis of
adhesions and chondroplasty. Results reported as N (%)

performed on the group of patients with lesions localized
to the medial or femoral condyle.

Results
Patient demographics

The patient population was composed of 48 (55.8%)
males and 38 (44.2%) females, with an average followup of 5.4 ± 1.4 years. In the osteochondral group 70.8%
were male, compared with 50% in the chondral group
(P = 0.133). The mean age at surgery in patients with
osteochondral lesions was 32.3 ± 11.1 years, compared
with 37.3 ± 10.8 years in patients of chondral etiology (P = 0.067). The mean BMI (kg/m2) was 26.4 in the
osteochondral group and 29.2 in the chondral group
(P = 0.068). Nine (37.5%) patients in the osteochondral
group underwent a concomitant procedure, compared
with 32 (51.6%) in the chondral group (P = 0.350). A
total of 56 patients (90.3%) in the chondral group and 16
patients (66.6%) in the osteochondral group underwent a
surgical procedure on their affected knee prior to OCA
transplantation (Fig. 1). The rate of previous surgery was
significantly greater in the chondral group (P = 0.018).
The defect location and area is presented Table 3. The
difference in laterality between groups was not statistically significant (P = 0.141). In both groups, the medial
femoral condyle was the most frequent site of injury
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condyle only, the osteochondral group reported superior
scores on the KOOS JR. (P = 0.047), IKDC (P = 0.037),
and SF-12 (P = 0.011). Further, comparison between the
chondral group with concomitant procedures and those
without did not demonstrate a difference, as seen in Fig. 2
(KOOS JR. P = 0.25, IKDC P = 0.31, SF-12 P = 0.17).
Regression analysis controlling for age, sex, BMI, laterality, and presence of a concomitant procedure found
that patients with osteochondral pathology had better KOOS JR. (P = 0.003) and IKDC (P = 0.008) scores,
but there was no significant difference in SF-12 scores.
Among the subgroup of patients with condylar lesions
only, patients with osteochondral pathology had better
KOOS JR. scores (P = 0.034), but there was no significant
difference in IKDC or SF-12 scores.

Fig. 1 Comparison of previous surgeries by etiology. ACLR anterior
cruciate ligament reconstruction, LOA lysis of adhesions, ROH removal
of hardware, ACI autologous chondrocyte implantation

(74.2% osteochondral group versus 45.0% chondral
group), and the lateral trochlea was the least frequent
(3.2% osteochondral versus 7.3% chondral group). A total
of 7 (29.2%) patients in the osteochondral group and
27 (43.5%) patients in the chondral group were found
to have lesions in multiple locations (P = 0.221). After
grouping lesions of the medial and lateral condyles for
the purpose of univariate subgroup analysis, there were
19 patients in the osteochondral group (39.6%) and 29
patients in the chondral group (60.4%).
Patient reported outcomes

At final follow-up, patients who underwent OCA transplantation for osteochondral pathology reported significantly greater functional outcome scores compared with
those with chondral pathology. The mean KOOS JR.
score was 83.2 for the osteochondral group and 69.4 for
the chondral group (P = 0.005). The mean IKDC scores
were 74.2 and 58.3 for the osteochondral and chondral groups (P = 0.007), respectively. The osteochondral
group had a mean SF-12 score of 50.4 compared with a
mean of 44.4 (P = 0.003) for the chondral group. Among
patients with lesions localized to the medial or lateral

Failures and revisions

There were 20 (32.3%) failures in the chondral group
compared with 2 (8.3%) in the osteochondral group
(P = 0.045). Among the subgroup of patients with condylar lesions only, there was one failure in the osteochondral group and nine failures in the chondral group
(P = 0.065). Regression analysis found that that the difference in failure rates between groups was not statistically
significant (P = 0.164).
Of the two patients who failed treatment in the osteochondral group, both underwent revision OCAs and one
eventually progressed to total knee arthroplasty (TKA).
Of the 20 failures in the chondral group, 4 progressed to
autologous chondrocyte implantation and 9 progressed
to total (7) or partial (2) knee arthroplasty. There were
four patients who underwent revision OCAs, and one
who underwent microfracture due to avascular necrosis
of the allograft plug. One patient, who initially received
a five-plug allograft transplantation, required subsequent
loose body removal and chondroplasty because one
of the five plugs had failed and was floating in the joint
space. Finally, there was one patient who developed a
subchondral cyst that required lysis of adhesions and retrograde drilling of the patella.

Table 3 Comparison of lesion location and size (mm2) between osteochondral and chondral defects
Osteochondral
Medial femoral condyle
Lateral femoral condyle
Patella

Chondral

P-value

23 (74.2%), 501.28 ± 343.33 mm2

49 (45.0%), 487.55 ± 240.71 mm2

0.865

2 (6.5%), 412.00 ± 124.45 mm2

24 (22.0%), 391.50 ± 193.34 mm2

0.886

2

4 (12.9%), 476.56 ± 96.34 mm
1 (3.2%), 625.00 ± 0.00 mm2

Medial trochlea

1 (3.2%), 450.00 ± 0.00 mm2

Lateral trochlea
−

17 (15.6%), 443.13 ± 286.03 mm2

0.825

11 (10.1%), 259.70 ± 150.28 mm2

–

8 (7.3%), 308.25 ± 111.34 mm2

Results reported as mean ± standard deviation. Indicates group sizes are too small for adequate comparison between groups

–
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Fig. 2 Comparison of functional outcome by etiology in which OCA was performed with or without concomitant procedures. KOOS, JR., Knee
injury and Osteoarthritis Outcome Score for Joint Replacement; IKDC, International Knee Documentation Committee; SF-12P, Short Form Health
Survey Physical

Discussion
This study evaluated the clinical and functional results
of patients following osteochondral allograft transplantation for osteochondral defects compared with isolated
chondral pathology. Patients with osteochondral defects
treated with OCA reported superior KOOS JR., IKDC,
and SF-12 scores compared with the isolated chondral
group. However, this effect was only seen in the KOOS
JR. and IKDC scores after regression.
Regarding the subgroup of patients with condylar
lesions, regression analysis demonstrated that patients
with osteochondral pathology had better KOOS JR.
scores, but there was no significant difference in IKDC
or SF-12 scores. These results suggest that patients who
undergo OCA for the treatment of osteochondral defects
may perform better than patients treated for isolated
chondral pathology, but further research is needed to
clarify this difference. Previous studies have supported
the efficacy of OCA for OCD [17, 18], AVN [19] and a
variety of pathologies involving articular cartilage [18,
20], but this is the first study comparing OCA for the
treatment of osteochondral and chondral lesions.
Demographic data, including age, sex, BMI, laterality, and the presence of a concomitant procedure, were
not significantly different between groups. Differences
in lesion location and grade were also reviewed to identify confounding factors contributing to the superior
outcomes seen in the osteochondral group. Previous

studies have demonstrated that lesion location is strongly
associated with postoperative outcomes [21, 22]. The
chondral cohort in our study had a higher percentage
of patellofemoral pathology (39.4%) compared with the
osteochondral group (12.9%). Gracitelli et al [23] demonstrated worse survivorship and functional outcomes
of patellar OCAs at 5 and 10 years when compared
with outcomes of femoral condyle OCAs reported by
Emmerson et al. [18]. However, the latter study did not
differentiate between OCA treatment for chondral or
osteochondral etiology [18]. Therefore, the higher propensity of patellofemoral defects in the chondral group
may be a confounder to the inferior clinical outcomes
seen. In contrast, it is unlikely that lesion grade was the
driving factor for the superior outcomes reported in the
osteochondral group. While the osteochondral group
had a higher lesion grade (3.9 versus 3.8), the difference
was not statistically significant (P = 0.234), and previous
studies have demonstrated that lesion grade does not
impact clinical outcomes [24].
The number of operations prior to OCA may have contributed to the difference in functional outcome scores.
Frank et al. found previous surgical procedures to be an
independent predictor of OCA failure [9]. In the present
study, 56 (90.3%) patients in the chondral cohort underwent prior surgery compared with 16 (66.6%) in the osteochondral group (P = 0.018), with the majority related to
chondroplasty and partial meniscectomy. Although there
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were no statistically significant differences with regard to
the proportion of patients who underwent a concomitant
procedure between the two groups, 12 (37.5%) patients in
the chondral group required a tibial tubercle osteotomy
compared with only one (11.1%) patient in the osteochondral group. There were also a greater number of ligamentous reconstructions involving the ACL and MPFL
in the chondral group (15 patients) compared with the
osteochondral group (0 patients), which contributed to
the lower functional outcome scores seen in the chondral
cohort.
This study has several limitations. First, there were
several eligible patients who were lost to follow-up. In
addition, some patients may have sought surgical care at
another institution without our knowledge, resulting in
an underestimation of reoperation and/or failure rates.
The number of patients lost to follow-up was similar for
both groups. There is also the potential for transfer bias
as patients with worse outcomes are more likely to return
for care. The lack of long-term imaging precluded additional investigation into graft healing and integrity as well
as progression and evaluation of arthritis. The retrospective study design did not allow for group randomization
and similar patient characteristics. Although similar, the
demographic data between the two populations were not
identical. There were also a higher number of patients in
the chondral group compared with the osteochondral
group with variable etiopathogenesis, and defect location. Additionally, long-standing x-rays were not routinely ordered, and differences in hip–knee–ankle angles
were unable to be assessed. There was also an insufficient
number of preoperative outcome scores in both groups.
However, lesion size, laterality, and grade were similar.
Additionally, analysis of postoperative radiographic healing was not possible.
There were a large number of patients with concomitant pathology addressed at the time of OCA transplantation, making it difficult to perform direct comparisons
between cohorts. An attempt was made to perform a
subgroup analysis of the concomitant procedures, but the
sample sizes were too small for meaningful comparison.
Our study is at risk for type II error due to small sample size. Last, this study included only patients treated by
surgeons at one institution that performs a high volume
of OCAs, which may introduce performance bias.

Conclusion
The findings of this study indicate that patients undergoing OCA for osteochondral defects may have greater
functional outcomes with similar failure rates compared with OCA transplantation for isolated chondral
pathology.
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